Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.44 USD | -4.49% | -11.22% | +23.05% |
May. 15 | Solid Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.05% | 295M | |
+9.80% | 118B | |
+10.10% | 106B | |
-11.49% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.61% | 15.97B | |
+6.51% | 14.03B | |
+16.35% | 11.67B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- Piper Sandler Upgrades Solid Biosciences to Overweight From Neutral, Adjusts Price Target to $20 From $8